[시장보고서]단백질 엔지니어링 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 최종 용도별, 기술별, 지역별, 부문별 예측(2024-2030년)

단백질 엔지니어링 시장 규모, 점유율, 동향 분석 리포트 : 제품 유형별, 최종 용도별, 기술별, 지역별, 부문별 예측(2024-2030년)

Protein Engineering Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments), By Protein Type (Insulin, Vaccines), By End-use (CROs, Pharma & Biotech Companies), By Technology, By Region, And Segment Forecasts, 2024 - 2030

상품코드 : 1493384

리서치사 : Grand View Research

발행일 : 2024년 05월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,596,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,041,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,930,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

단백질 엔지니어링 시장 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 단백질 엔지니어링 시장 규모는 2024-2030년 16.24%의 CAGR을 기록하며, 2030년에는 76억 2,000만 달러에 달할 전망입니다.

산업 성장을 이끄는 주요 요인 중 하나는 만성질환 치료에서 비 화학적 대체 의약품에 대한 세계 수요 증가입니다. 또한 단백질 기반 치료제가 좋은 임상 결과를 보여줌에 따라 기존 합성 의약품보다 선호도가 높아지면서 시장 성장을 가속화할 것으로 예상됩니다. 새로운 치료제를 개발하기 위한 연구와 발전을 위한 자금 지원과 같은 정부 활동 증가는 업계 성장에 더욱 영향을 미치고 있습니다.

또한 의료 인프라 개선, 의료비 지출 증가, 노인 인구 증가, 세계 의료 관련 R&D 투자 증가도 시장에 긍정적인 영향을 미치고 있습니다. 또한 단백질 엔지니어링 분야의 기술 발전의 성장은 주요 기업에게 매출 기회를 제공할 것으로 예상됩니다. 예를 들어 티에라 바이오사이언스는 2022년 2월 소비자가 단 몇 번의 클릭만으로 제조, 검증, 배송된 독특한 단백질 엔지니어링 제품을 받을 수 있는 E-Commerce 플랫폼인 '티에라 단백질 플랫폼'을 발표했습니다.

Tierra가 제공하는 플랫폼은 R&D에 사용할 수천 개의 단백질을 찾는 기존의 접근 방식에 대한 보다 빠르고 실용적인 대안을 제공합니다. 단백질 엔지니어링의 적용을 통해 산업 성장을 가속하고 있습니다. 예를 들어 2021년 7월 독일 아인트호벤 공과대학의 과학자들이 생체 발광 진단 키트를 개발했습니다. 이 키트는 개인의 면역 체계가 코로나바이러스에 반응하여 항체를 생성하는지 여부를 판단하는 데 사용할 수 있습니다. 마찬가지로, COVID-19 치료제를 위한 공학적 연구 및 개발에 대한 노력이 활발해짐에 따라 예측 기간 중 시장은 상당한 성장을 보일 것으로 예상됩니다.

단백질 엔지니어링 시장 보고서 하이라이트

2023년 가장 높은 시장 점유율을 차지한 것은 기기 제품 부문이었습니다. 단백질 엔지니어링 용도에서 크로마토그래피 분석을 위한 효율적이고 처리량이 높은 장비에 대한 높은 수요가 이 부문을 주도하고 있습니다.
합리적인 단백질 설계 기술 부문은 2023년 가장 큰 점유율을 차지했습니다. 단백질 리모델링 공학은 합리적 설계의 새로운 중요한 용도로, 높은 신뢰성과 빠른 처리 특성으로 인해 이 부문의 성장에 기여하는 주요 요인으로 작용하고 있습니다.
단클론 항체 단백질 유형 부문은 2023년 가장 큰 점유율을 차지했습니다. 모노클로널은 자가 면역 질환의 치료에 적용되고 있으며, 이러한 질환의 유병률이 증가함에 따라 이 부문은 급성장할 것으로 예상됩니다.
제약 및 생명공학 기업의 최종 용도 부문이 2023년 가장 큰 점유율을 차지했습니다. 생명 공학 및 제약 회사의 연구개발 비용 증가와 첨단 치료법을 개발하기 위한 정부의 자금 지원 및 지원 증가가 이 부문의 성장을 주도하고 있습니다.
북미가 2023년 가장 큰 점유율을 차지한 이유는 만성질환 치료를 위한 생물학적 제제의 사용이 증가하고 있으며, 이 지역의 R&D 활동을 위한 자금 조달 기회가 증가하고 있기 때문입니다.

단백질 유형 부문 대시보드
세계의 단백질 엔지니어링 시장에서 단백질 유형의 변동 분석
세계의 단백질 엔지니어링 시장 규모와 동향 분석, 단백질 유형별, 2018-2030년
인슐린
모노클로널 항체
백신
성장인자
집락자극인자
응고인자
인터페론
기타

제7장 단백질 엔지니어링 시장 : 최종 용도 비즈니스 분석

최종 용도 부문 대시보드
세계의 단백질 엔지니어링 시장의 최종 용도 변동 분석
세계의 단백질 엔지니어링 시장 규모와 동향 분석, 최종 용도별, 2018-2030년
학술연구기관
임상시험수탁기관(CRO)
제약·바이오테크놀러지 기업

제8장 단백질 엔지니어링 시장 : 제품, 기술, 단백질 유형, 최종 용도별 지역 추정·동향 분석

지역 대시보드
시장 규모와 예측 및 동향 분석, 2018-2030년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카

제9장 경쟁 구도

참여 기업
전략 매핑
기업 시장 현황 분석, 2023년
참여 기업의 개요
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Bruker Corporation
- PerkinElmer, Inc.
- Waters Corporation
- Bio-Rad Laboratories
- Merck KGaA
- Danaher Corporation
- Genscript Biotech Corp
- Amgen Inc.

KSA

영문 목차

영문목차

Protein Engineering Market Growth & Trends:

The global protein engineering market size is expected to reach USD 7.62 billion by 2030, registering a CAGR of 16.24% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the key factors fueling the industry's growth is the rising demand for non-chemical medicinal alternatives for the treatment of chronic diseases globally. Furthermore, due to the favorable clinical outcomes connected to protein-based treatments, these therapeutics are now preferred over conventional synthesized pharmaceuticals, which is expected to accelerate market growth. The rising number of government activities, such as funding research and advancement for engineering novel therapeutics further influence the industry growth.

In addition, the market is positively impacted by improvements in healthcare infrastructure, an increase in healthcare spending, growth in the geriatric population, and an increase in investments in health-related research & development globally. Furthermore, key companies are expected to have profitable opportunities due to the growth in technological advancements in the protein engineering field. For instance, in February 2022, Tierra Biosciences unveiled the Tierra Protein Platform, an e-commerce platform that enables consumers to receive unique protein engineering products manufactured, verified, and dispatched to them in only a few clicks.

The platform offered by Tierra offers a quicker and more practical alternative to conventional approaches for finding thousands of proteins for use in R&D. The COVID-19 pandemic has boosted the industry growth due to applications of protein engineering in the production of COVID-19 vaccines and diagnostics. A bioluminescent diagnostic kit, for instance, was developed in July 2021 by scientists at the Eindhoven University of Technology in Germany. It can be utilized to determine whether an individual's immune system is producing antibodies in reaction to the coronavirus. Similarly, it is anticipated that the market will witness substantial growth during the forecast period as a result of the rising R&D efforts for engineering COVID-19 treatments.

Protein Engineering Market Report Highlights:

The instruments product segment accounted for the highest market share in 2023. High demand for efficient and high throughput instruments for chromatographic analysis in protein engineering applications is driving the segment
The rational protein design technology segment accounted for the largest share in 2023. Protein remodeling engineering is an emerging and important application of rational design and serves as a major factor contributing to the growth of the segment due to its highly reliable and rapid processing attributes
The monoclonal antibodies protein type segment held the largest share in 2023. Monoclonal bodies find applications in the treatment of autoimmune disorders and with the rising prevalence of such diseases, the segment is anticipated to witness a rapid growth
The pharmaceutical and biotechnology companies end-use segment held the largest share in 2023. Rising R&D expenditure by biotechnology and pharmaceutical firms and increasing government funding and support for engineering advanced therapies are boosting the segment growth
North America accounted for the largest share in 2023 due to the rising use of biological medications for the treatment of chronic diseases, as well as rising funding opportunities in the region for R&D activities

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Protein Type
- 1.2.4. End-use
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
- 1.6.1. Primary Research
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing adoption of protein-based drugs
  - 3.2.1.2. Increasing research & development activities in the biopharmaceutical industry
  - 3.2.1.3. Growing funding opportunities for protein engineering
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High maintenance costs associated with protein engineering tools & instruments
  - 3.2.2.2. Limited availability of qualified researchers and need for advanced training in protein engineering
3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Protein Engineering Market: Product Business Analysis

4.1. Product Segment Dashboard
4.2. Global Protein Engineering Market Product Movement Analysis
4.3. Global Protein Engineering Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Instruments
- 4.4.1. Global Instruments Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Reagents
- 4.5.1. Global Reagents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Software & Services
- 4.6.1. Global Software & Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Protein Engineering Market: Technology Business Analysis

5.1. Technology Segment Dashboard
5.2. Global Protein Engineering Market Technology, Movement Analysis
5.3. Global Protein Engineering Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Rational Protein Design
- 5.4.1. Global Rational Protein Design Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Directed Evolution
- 5.5.1. Global Directed Evolution Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Hybrid Approach
- 5.6.1. Global Hybrid Approach Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. De Novo Protein Design
- 5.7.1. Global De Novo Protein Design Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Others
- 5.8.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Protein Engineering Market: Protein Type Business Analysis

6.1. Protein Type Segment Dashboard
6.2. Global Protein Engineering Market Protein Type Movement Analysis
6.3. Global Protein Engineering Market Size & Trend Analysis, by Protein Type, 2018 to 2030 (USD Million)
6.4. Insulin
- 6.4.1. Global Insluin Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Monoclonal Antibodies
- 6.5.1. Global Monoclonal Antibodies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Vaccines
- 6.6.1. Global Vaccines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Growth Factors
- 6.7.1. Global Growth Factors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Colony Stimulating Factors
- 6.8.1. Global Colony Stimulating Factors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Coagulation Factors
- 6.9.1. Global Coagulation Factors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.10. Interferons
- 6.10.1. Global Interferons Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.11. Others
- 6.11.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Protein Engineering Market: End-use Business Analysis

7.1. End-use Segment Dashboard
7.2. Global Protein Engineering Market End-use Movement Analysis
7.3. Global Protein Engineering Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
7.4. Academic Research Institutes
- 7.4.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Contract Research Organizations
- 7.5.1. Global Contract Research Organizations Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Pharmaceutical & Biotechnology Companies
- 7.6.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Protein Engineering Market: Regional Estimates & Trend Analysis by Product, Technology, Protein Type, and End-use

8.1. Regional Dashboard
8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
8.3. North America
- 8.3.1. North America Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
  - 8.3.2.1. Key Country Dynamics
  - 8.3.2.2. Competitive Scenario
  - 8.3.2.3. Regulatory Framework
  - 8.3.2.4. U.S. Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
  - 8.3.3.1. Key Country Dynamics
  - 8.3.3.2. Competitive Scenario
  - 8.3.3.3. Regulatory Framework
  - 8.3.3.4. Canada Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Europe
- 8.4.1. Europe Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. UK
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. UK Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Germany
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Germany Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. France
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Competitive Scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. France Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Italy
  - 8.4.5.1. Key Country Dynamics
  - 8.4.5.2. Competitive Scenario
  - 8.4.5.3. Regulatory Framework
  - 8.4.5.4. Italy Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Spain
  - 8.4.6.1. Key Country Dynamics
  - 8.4.6.2. Competitive Scenario
  - 8.4.6.3. Regulatory Framework
  - 8.4.6.4. Spain Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Denmark
  - 8.4.7.1. Key Country Dynamics
  - 8.4.7.2. Competitive Scenario
  - 8.4.7.3. Regulatory Framework
  - 8.4.7.4. Denmark Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.8. Sweden
  - 8.4.8.1. Key Country Dynamics
  - 8.4.8.2. Competitive Scenario
  - 8.4.8.3. Regulatory Framework
  - 8.4.8.4. Sweden Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.9. Norway
  - 8.4.9.1. Key Country Dynamics
  - 8.4.9.2. Competitive Scenario
  - 8.4.9.3. Regulatory Framework
  - 8.4.9.4. Norway Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Asia Pacific
- 8.5.1. Asia Pacific Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Japan
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Japan Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. China
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. China Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. India
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. India Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Australia
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Australia Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Thailand
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Thailand Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. South Korea
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. South Korea Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Latin America
- 8.6.1. Latin America Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Brazil Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Mexico
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. Mexico Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. Argentina
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. Argentina Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. MEA
- 8.7.1. MEA Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. South Africa
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. South Africa Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Saudi Arabia
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Saudi Arabia Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.4. UAE
  - 8.7.4.1. Key Country Dynamics
  - 8.7.4.2. Competitive Scenario
  - 8.7.4.3. Regulatory Framework
  - 8.7.4.4. UAE Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
  - 8.7.5.1. Key Country Dynamics
  - 8.7.5.2. Competitive Scenario
  - 8.7.5.3. Regulatory Framework
  - 8.7.5.4. Kuwait Protein Engineering Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2023
9.4. Participant's Overview
- 9.4.1. Agilent Technologies, Inc.
  - 9.4.1.1. Overview
  - 9.4.1.2. Financial Performance
  - 9.4.1.3. Product Benchmarking
  - 9.4.1.4. Strategic Initiatives
- 9.4.2. Thermo Fisher Scientific Inc.
  - 9.4.2.1. Overview
  - 9.4.2.2. Financial Performance
  - 9.4.2.3. Product Benchmarking
  - 9.4.2.4. Strategic Initiatives
- 9.4.3. Bruker Corporation
  - 9.4.3.1. Overview
  - 9.4.3.2. Financial Performance
  - 9.4.3.3. Product Benchmarking
  - 9.4.3.4. Strategic Initiatives
- 9.4.4. PerkinElmer, Inc.
  - 9.4.4.1. Overview
  - 9.4.4.2. Financial Performance
  - 9.4.4.3. Product Benchmarking
  - 9.4.4.4. Strategic Initiatives
- 9.4.5. Waters Corporation
  - 9.4.5.1. Overview
  - 9.4.5.2. Financial Performance
  - 9.4.5.3. Product Benchmarking
  - 9.4.5.4. Strategic Initiatives
- 9.4.6. Bio-Rad Laboratories
  - 9.4.6.1. Overview
  - 9.4.6.2. Financial Performance
  - 9.4.6.3. Product Benchmarking
  - 9.4.6.4. Strategic Initiatives
- 9.4.7. Merck KGaA
  - 9.4.7.1. Overview
  - 9.4.7.2. Financial Performance
  - 9.4.7.3. Product Benchmarking
  - 9.4.7.4. Strategic Initiatives
- 9.4.8. Danaher Corporation
  - 9.4.8.1. Overview
  - 9.4.8.2. Financial Performance
  - 9.4.8.3. Product Benchmarking
  - 9.4.8.4. Strategic Initiatives
- 9.4.9. Genscript Biotech Corp
  - 9.4.9.1. Overview
  - 9.4.9.2. Financial Performance
  - 9.4.9.3. Product Benchmarking
  - 9.4.9.4. Strategic Initiatives
- 9.4.10. Amgen Inc.
  - 9.4.10.1. Overview
  - 9.4.10.2. Financial Performance
  - 9.4.10.3. Product Benchmarking
  - 9.4.10.4. Strategic Initiatives